Changes in P14ARF do not playa primary role in human chondrosarcoma tissues

被引:7
作者
Asp, J
Brantsing, C
Benassi, MS
Inerot, S
Sangiorgi, L
Picci, P
Lindahl, A [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Res Ctr Endocrinol & Metab, S-41345 Gothenburg, Sweden
[2] Ist Ortoped Rizzoli, Lab Ric Oncol, Bologna, Italy
[3] Sahlgrens Univ Hosp, Dept Orthopaed, Sect Orthoped Oncol, S-41345 Gothenburg, Sweden
关键词
p14(ARF); exon1; beta; chondrosarcoma;
D O I
10.1002/ijc.1398
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The locus encoding the tumor suppressor p16 has been found to code for a second, different protein. This protein, p14(ARF), has been shown to protect p53 from degradation. Like p16, its gene is often altered in different cancers. In this study, the first unique exon, exon 1 beta, of p14(ARF), has been studied in 22 chondrosarcoma tissues using polymerase chain reaction, DNA sequencing and methylation-specific polymerase chain reaction. One chondrosarcoma was found to have exon 1 beta homozygously deleted, but neither mutations nor methylations were found in any of the chondrosarcomas. This indicates that genetic changes of p14(ARF) are a rare event in chondrosarcoma. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:703 / 705
页数:3
相关论文
共 19 条
[11]   SP1 SITES IN THE MOUSE APRT GENE PROMOTER ARE REQUIRED TO PREVENT METHYLATION OF THE CPG ISLAND [J].
MACLEOD, D ;
CHARLTON, J ;
MULLINS, J ;
BIRD, AP .
GENES & DEVELOPMENT, 1994, 8 (19) :2282-2292
[12]  
MAO L, 1995, CANCER RES, V55, P2995
[13]   The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53 [J].
Robertson, KD ;
Jones, PA .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6457-6473
[14]   Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus [J].
Robertson, KD ;
Jones, PA .
ONCOGENE, 1999, 18 (26) :3810-3820
[15]  
STONE S, 1995, CANCER RES, V55, P2988
[16]   The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 [J].
Stott, FJ ;
Bates, S ;
James, MC ;
McConnell, BB ;
Starborg, M ;
Brookes, S ;
Palmero, I ;
Ryan, K ;
Hara, E ;
Vousden, KH ;
Peters, G .
EMBO JOURNAL, 1998, 17 (17) :5001-5014
[17]   Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma [J].
Tsuchiya, T ;
Sekine, K ;
Hinohara, S ;
Namiki, T ;
Nobori, T ;
Kaneko, Y .
CANCER GENETICS AND CYTOGENETICS, 2000, 120 (02) :91-98
[18]  
Xing EP, 1999, CLIN CANCER RES, V5, P2704
[19]   ARF promotes MDM2 degradation and stabilizes p53:: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways [J].
Zhang, YP ;
Xiong, Y ;
Yarbrough, WG .
CELL, 1998, 92 (06) :725-734